About Derma Sciences
Derma Sciences is a company based in Princeton (United States) founded in 1984 was acquired by Integra LifeSciences in January 2017. Derma Sciences has raised $18.16 million across 9 funding rounds from investors including Integra LifeSciences and HHS. The company has 123 employees as of December 31, 2017. Derma Sciences has completed 1 acquisition, including BioD. Derma Sciences operates in a competitive market with competitors including Imbed Biosciences, Adocia, Ensoma, Tenaya Therapeutics and Orca Bio, among others.
- Headquarter Princeton, United States
- Employees 123 as on 31 Dec, 2017
- Stage Public
-
Sectors
TechnologyAerospace, Defense & Maritime Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Derma Sciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.16 M (USD)
in 9 rounds
-
Latest Funding Round
$29.07 M (USD), Post-IPO
Jul 05, 2011
-
Investors
Integra LifeSciences
& 1 more
-
Employee Count
123
as on Dec 31, 2017
- Investments & Acquisitions
-
Acquired by
Integra LifeSciences
(Jan 10, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Derma Sciences
Unlock access to complete
Leadership Team
7 people
Sales and Marketing
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Derma Sciences
Derma Sciences has successfully raised a total of $18.16M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $29.07 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Derma Sciences
Derma Sciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Integra LifeSciences and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Diversified medical devices are developed for healthcare applications.
|
Locked | Locked | Locked |
Investor details for Derma Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Derma Sciences
Derma Sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BioD.
Investment portfolio details for Derma Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Novel biologic products from placental tissues are developed and commercialized.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Derma Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Derma Sciences
Detailed financials for Derma Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Derma Sciences Comparisons
Peer comparison for Derma Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Derma Sciences
Derma Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Adocia, Ensoma, Tenaya Therapeutics and Orca Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| Locked | Locked | Locked |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| Locked | Locked | Locked |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| Locked | Locked | Locked |
Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.
|
Detailed competitors of Derma Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Derma Sciences
Complete news archive for Derma Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Derma Sciences
Derma Sciences was founded in 1984 and raised its 1st funding round 18 years after it was founded.
Derma Sciences is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Derma Sciences is a funded company, having raised a total of $18.16M across 9 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Derma Sciences is 123.
The company was founded in 1984 and is headquartered in Princeton, United States. Focus is placed on the healthcare sector, specifically tissue regeneration and wound care. Operations are structured into three segments: pharmaceutical wound care, advanced wound care, and traditional wound care products. These segments support the development and distribution of related medical solutions for various applications.
Derma Sciences's top competitors include Imbed Biosciences, Adocia and Tenaya Therapeutics.
Derma Sciences has made 1 acquisition, including BioD.
Derma Sciences has 2 investors. Key investors include Integra LifeSciences, and HHS.